北京领新博瑞生物科技有限公司致力于创新化学偶联细胞技术在各类疾病治疗中的应用。公司由国内著名高校专家联合发起创立,研发团队经验丰富,已经启动*管线的IND申报,数个管线在研发阶段。公司正搭建偶联技术平台、细胞培养平台、和创新靶点开发平台,通过高效、安全、工艺友好的偶联方案,实现多肽、抗体、细胞之间工价偶联。公司将在肿瘤、免疫系统疾病领域布局临床管线,降低患者和医保支付成本,提高治疗效果,改善患者生存质量。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows